H_2受体拮抗剂土要用于治疗溃疡病,卓-艾综合征,反流性食管炎和预防应激性溃疡,也可用于消化不良综合征,对早期的 H_2受体拈抗剂耐受性和安全性两组大样本的临床研究,其结果中有关心血管副作用的发生率分别为18/10~5和6/7911。此外,关于 H_2受体拈抗剂导致严重心脏并发病的个案报道也不少见。除甲氰咪胍和雷尼替丁外,近几年还不断开发 H 2 receptor antagonist is used in the treatment of ulcer disease, Zhuo-Ai syndrome, reflux esophagitis and the prevention of stress ulcer can also be used for indigestion syndrome, the early H 2 receptor antagonist tolerance The clinical and clinical studies of two large groups of patients with sex and safety found that the incidence of cardiovascular side effects was 18 / 10-5 and 6/7911, respectively. In addition, it is not uncommon to report cases of H 2 receptor antagonists that cause severe cardiac complications. In addition to cimetidine and ranitidine, in recent years continue to develop